Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats
- Authors
- Lee, Sang Kyu; Kim, Yoon; Kim, Tae Kon; Im, Guang-Jin; Lee, Bong-Yong; Kim, Dong-Hyun; Jin, Changbae; Yoo, Hye Hyun
- Issue Date
- Feb-2009
- Publisher
- Elsevier BV
- Keywords
- Mirodenafil; Sildenafil; Tissue distribution; LC-MS/MS
- Citation
- Journal of Pharmaceutical and Biomedical Analysis, v.49, no.2, pp 513 - 518
- Pages
- 6
- Indexed
- SCOPUS
- Journal Title
- Journal of Pharmaceutical and Biomedical Analysis
- Volume
- 49
- Number
- 2
- Start Page
- 513
- End Page
- 518
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/41391
- DOI
- 10.1016/j.jpba.2008.11.004
- ISSN
- 0731-7085
1873-264X
- Abstract
- The purpose of the present study was to determine sildenafil and a novel PDE-5 inhibitor, mirodenafil in the plasma and corpus cavernosum tissue of rats to compare their pharmacokinetic Properties. The concentrations of mirodenafil and sildenafil in the rat plasma and corpus cavernosum tissue samples were analyzed using LC-MS/MS after a single oral administration at a dose of 40 mg/kg to rats. Although the T-max, D lambda(1/2) and MRT were not different between mirodenafil and sildenafil, the C-max and AUC of mirodenafil were significantly higher than those of sildenafil in the plasma and corpus cavernosum tissue. Consequently mirodenafil remained longer than sildenafil in the plasma and tissue. This may provide pharmacokinetic evidence for assessment of the in vivo efficacy of mirodenafil and sildenafil. (C) 2008 Elsevier B.V. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.